And Mr. Hudson, yes or no, did Sanofi conduct 497 million euro of stock buybacks in 2022 or roughly equivalent to 544 million US dollars? That's correct, Senator, thank you. We are taking steps in the right direction in the legislation that we will be working on tomorrow in this committee. And I am hopeful that we are able to specifically tackle insulin prices later this year. But we can't ignore the business practices of the companies that have come before us today. (05:18–05:24)
CLAIM
Asserts that the committee is working on legislation to address issues discussed.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
